Skip to main content

Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors: an exploratory study from Spanish GETH/TC Centers.

Open
  • Protocol code: TORMENT
  • EudraCT code: No aplica
  • Service: Hematology and Hematotherapy
  • Principal investigator:  Pérez González, Ana
  • Pathology: Tumors
  • Phase: Fase III